Official Title
Remdesivir in COVID-19 Treatment: A Randomised Trial
Brief Summary
COVID 19 treatment using Remedesvir.
Detailed Description
COVID 19 treatment using Remedesvir. Is this drug effective?
Completed
COVID
Drug: Remdesivir
Remdesivir as antiviral drug
Other: Standard of care treatment
Standard of care treatment
Eligibility Criteria
Inclusion Criteria:
- COVID 19 patients
Exclusion Criteria:
- allergy or contraindication to the drug
Eligibility Gender
All
Eligibility Age
Minimum: N/A ~ Maximum: N/A
Countries
Egypt
Locations
Tanta university hospital, Assuit University, Ainshams University
Tanta, Egypt
Sherief Abd-Elsalam, ass. prof., Principal Investigator
Tanta University Faculty of medicine
Tanta University
NCT Number
MeSH Terms
Remdesivir